سعر Lantopep 30 mg 20 caps 2026

Lantopep dexlansoprazole 30 mg capsules, pack of 20 (Mash Premiere, Egypt); proton pump inhibitor.

• Healing of all grades of erosive oesophagitis (up to 8 weeks).Population: Patients 12 years and olderDailyMed (U.S. National Library of Medicine)
• Maintenance of healed erosive oesophagitis and relief of heartburn.Population: Patients 12 years and olderDailyMed (U.S. National Library of Medicine)
• Treatment of heartburn associated with symptomatic non-erosive GERD (4 weeks).Population: Patients 12 years and olderDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (>=2%, more than placebo): diarrhoea, abdominal pain, nausea, upper respiratory tract infection, vomiting.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to any component (reactions may include anaphylaxis, angioedema, bronchospasm, acute tubulointerstitial nephritis, urticaria).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Co-administration with rilpivirine-containing products.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• In adults, symptomatic response does not exclude gastric malignancy; consider further follow-up and testing.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Acute tubulointerstitial nephritis: discontinue and evaluate.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• PPI therapy may increase the risk of Clostridioides difficile-associated diarrhoea.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Rilpivirine-containing productsContraindicated: PPIs reduce rilpivirine exposure.DailyMed (U.S. National Library of Medicine)
• AntiretroviralsEffect of PPIs on antiretrovirals is variable; consult the antiretroviral labelling.DailyMed (U.S. National Library of Medicine)

• No studies of dexlansoprazole in pregnant women; observational studies of lansoprazole (its racemate) showed no association with adverse pregnancy outcomes; lansoprazole in rats reduced offspring bone parameters at 1.8 times the maximum human dexlansoprazole dose.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk; lansoprazole is present in rat milk; weigh benefits of breastfeeding against maternal need and potential infant effects.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Dexlansoprazole: R-enantiomer of lansoprazole; inhibits the gastric H+/K+-ATPase (proton pump), blocking the final step of acid secretion.